Last reviewed · How we verify

NCT03761719

The Influence of HDL Function on Cognitive Function

Completed Last updated 15 July 2020
What this trial tests

trial testing No intervention in Older People With Diabetes Mellitus in 145 participants. Completed in 31 October 2019.

Timeline
30 July 2018
Primary endpoint
31 October 2019
31 October 2019

Quick facts

Lead sponsorChinese University of Hong Kong
StatusCompleted
Study typeOBSERVATIONAL
Enrollment145
Start date30 July 2018
Primary completion31 October 2019
Estimated completion31 October 2019
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

65 and older, any sex, with Older People With Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Older people with diabetes mellitus are at risk of cognitive decline and dementia. We therefore propose to examine the potential influence of HDL function on global cognitive function and brain structures in older people with DM.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study.
    Huang C, Zhang J, Huang J, Li H, et al · · 2023 · cited 8× · PMID 37386457 · DOI 10.1186/s12944-023-01829-9

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03761719.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing